Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fulvia Ferrazzi

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Leukemia|April 24, 2026
Prevalence and characterization of germline RAS pathway variants in children with chronic myeloid leukemiaTabita Ghete, Laura Gaschler, Manuela Krumbholz, et al.
The American Journal of Pathology|April 22, 2021
Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte DifferentiationFlorian Haller, Lea D Schlieben, Fulvia Ferrazzi, et al.
Oncogene|October 12, 2022
Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brainRaquel Blazquez, Han-Ning Chuang, Britta Wenske, et al.
Virchows Archiv : an International Journal of Pathology|April 8, 2026
Prognostic value of the tumor immune microenvironment, PD-L1 and p16<sup>INK4A</sup> in penile squamous cell carcinomaAugust Fiegl, Miriam Angeloni, Jan Mink, et al.
Oncoimmunology|February 16, 2017
FAM13A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survivalFelix Eisenhut, Lisanne Heim, Sonja Trump, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneityJulian Hübner, Marah Alsalkini, Rhonda McFleder, et al.
Histopathology|January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsVeronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 22, 2020
Sox11 is an Activity-Regulated Gene with Dentate-Gyrus-Specific Expression Upon General Neural ActivationJulia von Wittgenstein, Fang Zheng, Marie-Theres Wittmann, et al.
The Journal of Pathology. Clinical Research|March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testingMiriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
Cancer Research|January 19, 2018
Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer CellsAnnemarie Schwab, Aarif Siddiqui, Maria Eleni Vazakidou, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Leukemia|April 24, 2026
Prevalence and characterization of germline RAS pathway variants in children with chronic myeloid leukemiaTabita Ghete, Laura Gaschler, Manuela Krumbholz, et al.
The American Journal of Pathology|April 22, 2021
Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte DifferentiationFlorian Haller, Lea D Schlieben, Fulvia Ferrazzi, et al.
Oncogene|October 12, 2022
Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brainRaquel Blazquez, Han-Ning Chuang, Britta Wenske, et al.
Virchows Archiv : an International Journal of Pathology|April 8, 2026
Prognostic value of the tumor immune microenvironment, PD-L1 and p16<sup>INK4A</sup> in penile squamous cell carcinomaAugust Fiegl, Miriam Angeloni, Jan Mink, et al.
Oncoimmunology|February 16, 2017
FAM13A is associated with non-small cell lung cancer (NSCLC) progression and controls tumor cell proliferation and survivalFelix Eisenhut, Lisanne Heim, Sonja Trump, et al.
Journal for Immunotherapy of Cancer|June 3, 2026
Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneityJulian Hübner, Marah Alsalkini, Rhonda McFleder, et al.
Histopathology|January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsVeronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
Cerebral Cortex (New York, N.Y. : 1991)|February 22, 2020
Sox11 is an Activity-Regulated Gene with Dentate-Gyrus-Specific Expression Upon General Neural ActivationJulia von Wittgenstein, Fang Zheng, Marie-Theres Wittmann, et al.
The Journal of Pathology. Clinical Research|March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testingMiriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
Cancer Research|January 19, 2018
Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer CellsAnnemarie Schwab, Aarif Siddiqui, Maria Eleni Vazakidou, et al.
Pageof 8